Stocks Health care VICP

OTC · Health care

Vicapsys Life Sciences, Inc. (VICP)

It posted a net loss of $1.3M. At September 30, 2024 it held $89.6K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on January 10, 2025.

Watch VICP in 60 seconds

What Vicapsys Life Sciences, Inc. does

Vicapsys Life Sciences, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker VICP.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Vicapsys Life Sciences, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. March 27, 2025
   Deregistration 15-12G
2. March 21, 2025
   Passive stake (5% or more) SCHEDULE 13G
3. January 10, 2025
   Quarterly report 10-Q · period to September 30, 2024Diluted EPS -$0.01 versus -$0.01.
4. January 10, 2025
   Quarterly report 10-Q · period to June 30, 2024Diluted EPS -$0.01 versus $0.00.
5. January 10, 2025
   Quarterly report 10-Q · period to March 31, 2024Diluted EPS -$0.01 versus -$0.01.
6. October 21, 2024
   Annual report 10-K · period to December 31, 2023Diluted EPS -$0.03 versus -$0.03.
7. June 27, 2024
   Form SEC STAFF ACTION filing SEC STAFF ACTION
8. December 27, 2023
   Material agreement 8-K
9. November 14, 2023
   Quarterly report 10-Q · period to September 30, 2023Diluted EPS was -$0.01.
10. August 14, 2023
    Quarterly report 10-Q · period to June 30, 2023Diluted EPS was $0.00.

Recent insider filings (Forms 3, 4 and 144): 10, the latest on March 21, 2025. Insider transactions on SEC

Who owns VICP

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about VICP

What does Vicapsys Life Sciences, Inc. do?

Vicapsys Life Sciences, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker VICP.

Is Vicapsys Life Sciences, Inc. profitable?

No. Over the twelve months to September 30, 2024 it reported a net loss of $1.3M.

When did Vicapsys Life Sciences, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on January 10, 2025. It covers the period to September 30, 2024. Its newest filing of any kind is the deregistration from March 27, 2025.

Similar companies

Compare VICP with

Compare VICP with any company

Follow VICP

Get an email when Vicapsys Life Sciences, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow VICP: get an email when it files

Where the numbers come from

Financial figures are the values Vicapsys Life Sciences, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.